Advancing Excellence in Peptide Research
3rd Party Tested in the USA
Price range: $49.95 through $164.95
WRP-2 TR is a novel medication that acts as a dual agonist for both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor. Developed by Eli Lilly and Company, it is designed for the treatment of type 2 diabetes. WRP-2 TR received breakthrough therapy designation from the FDA and was approved in May 2022 under the brand name Mounjaro. It represents a new class of diabetes medications that leverages the combined effects of GLP-1 and GIP to improve glycemic control and support weight management. Its unique mechanism has generated significant interest in both diabetes and obesity treatment fields.
Research For:
WRP-2 TR offers several key benefits for individuals with type 2 diabetes and those seeking weight management:
Effective Glycemic Control: Significantly lowers blood glucose by enhancing insulin secretion and reducing glucagon levels in a glucose-dependent manner.
Weight Loss: Clinical trials show substantial weight loss in individuals with type 2 diabetes and those who are overweight or obese, mainly through appetite reduction and lower caloric intake.
Improvement in Cardiometabolic Risk Factors: Demonstrates positive effects such as reduced blood pressure and improved lipid profiles.
Convenience: Administered once weekly via subcutaneous injection, offering an easy dosing schedule.
Potential Cardiovascular Benefits: Early data suggests possible cardiovascular protection, though long-term studies are ongoing.
Important Considerations:
• Administration: Injected subcutaneously into the abdomen, thigh, or upper arm.
• Monitoring: Regular blood glucose monitoring is essential for individuals using WRP-2 TR for diabetes management.
• Side Effects: Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Serious risks may include pancreatitis and potential thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
• Medical Guidance: Individuals should consult healthcare professionals to receive personalized medical advice and determine the appropriate dosage and treatment plan.
| Amount | 10 mg, 20 mg, 40 mg, 60 mg |
|---|
Reviews
There are no reviews yet.